David Favre Email

Chief Development Officer (CDO) . Splice Bio

Current Roles

Employees:
48
Revenue:
$7.4M
About
Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company's platform has the potential to address two existing limitations of adeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted. www.splice.bio.
Splice Bio Address
Baldiri Reixac 10-12
Barcelona, null
Spain
Splice Bio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.